AOP ORPHAN
LIVE

Serial Number

79190575

Owner

AOP Orphan Pharmaceuticals AG

Attorney

Michael Fedrick

Filing Date

Jun 2, 2016

Add to watchlist:

No watchlists yet
View on USPTO

AOP ORPHAN Trademark

Serial Number: 79190575 • Registration: 5148640

AOP ORPHAN is a trademark filed by AOP Orphan Pharmaceuticals AG on June 2, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

AOP Orphan Pharmaceuticals AG (12 trademarks)

Wilhelminenstraße 91/IIf

Entity Type: 99

AOP ORPHAN PHARMACEUTICALS GMBH (16 trademarks)

LEOPOLD-UNGAR-PLATZ 2
VIENNA 1190 , AT

Entity Type: 27

Trademark Details

Filing Date

June 2, 2016

Registration Date

February 28, 2017

Published for Opposition

December 13, 2016

Cancellation Date

September 15, 2023

Goods & Services

Medical advisory and assistance services in the field of medication

Distribution of medication

Medical and pharmaceutical research and development in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; scientific research and development services in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; industrial research in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; professional consultancy services in the fields of medical and pharmaceutical research and development; contract research services in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; computer programming

Pharmaceutical and medical preparations in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; sanitary preparations for medical purposes

Advertising, marketing and promotional consultancy in the field of medication

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Jun 11, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 22, 2024 INTS
INVALIDATION PROCESSED
May 22, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 15, 2024 INTR
CANCELLED SECTION 71
Sep 15, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 28, 2022 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2021 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 26, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 8, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 14, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 14, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2016 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2016 TROA
REFUSAL PROCESSED BY IB
Oct 16, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2016 RFCS
REFUSAL PROCESSED BY MPU
Sep 29, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2016 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 30, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 25, 2016 REPR